GlassScriptPhysician profile
Natalie Connolly
NPI 1023303880
$699.31
in general payments reported to CMS, 2019-2025
15 companies · $63.59 in 2025
The $63.59 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.29 · 2021: $202 · 2022: $222 · 2023: $141 · 2024: $46.67 · 2025: $63.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $114.53 | 2022-2024 | Azstarys |
| Merck Sharp & Dohme LLC | $86.00 | 2021-2023 | Rotateq, Vaxneuvance, Gardasil 9 |
| Glaxosmithkline, LLC. | $84.69 | 2021-2025 | Bexsero, Rotarix, Pediarix |
| Adlon Therapeutics L.P. | $77.07 | 2021 | |
| Sanofi Pasteur INC. | $54.09 | 2021-2022 | |
| Seqirus USA INC | $51.12 | 2021-2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Alexion Pharmaceuticals, INC. | $41.78 | 2023 | Strensiq |
| Hologic Sales and Service, LLC | $36.62 | 2023 | Aptima, Thinprep 2000 Processor |
| Cranial Technologies, INC | $34.04 | 2022-2025 | Doc Band |
| Sobi, INC | $28.43 | 2021 | |
| Ironshore Pharmaceuticals INC. | $23.29 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $21.24 | 2022 | |
| Baxter Healthcare | $18.03 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.86 | 2022 | |
| Pfizer INC. | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Connolly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.